Central sleep apnea treatment in heart failure: are we counting chickens before they are hatched?

References

• Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Fail.10(10), 933–989 (2008).
   PubMed Web of Science ®Google Scholar
• Maggioni AP, Dahlström U, Filippatos G et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur. J. Heart Fail.12(10), 1076–1084 (2010).
   PubMed Web of Science ®Google Scholar
• Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Circulation118(10), 1080–1111 (2008).
   PubMed Web of Science ®Google Scholar
• Yumino D, Bradley TD. Central sleep apnea and Cheyne–Stokes respiration. Proc. Am. Thorac. Soc.5, 226–236 (2008).
   PubMedGoogle Scholar
• Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation13, 121 (14), 1598–1605 (2010).
   Google Scholar
• Kuzniar TJ, Pusalavidyasagar S, Gay PC, et al. Natural course of complex sleep apnea: a retrospective study. Sleep Breath.12, 135–139 (2008).
   PubMed Web of Science ®Google Scholar
• Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation103, 238–243 (2001).
   PubMed Web of Science ®Google Scholar
• Ryan CM, Floras JS, Logan AG et al. Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur. Respir. J.35(3), 592–597 (2010).
   PubMed Web of Science ®Google Scholar
• Hagenah G, Zapf A, Schüttert JB. Cheyne–Stokes respiration and prognosis in modern-treated congestive heart failure. Lung188(4), 309–313 (2010).
   PubMed Web of Science ®Google Scholar
• Vazir A, Morrell MJ, Hastings PC, McIntyre HF, Simonds AK, Cowie MR. Central sleep apnoea predicts mortality even in patients with mild chronic heart failure: a 6-year follow-up study. Heart95, 88–92 (2009).
   Google Scholar
• Yumino D, Wang H, Floras JS et al. Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart95(10), 819–824 (2009).
   PubMed Web of Science ®Google Scholar
• Bitter T, Westerheide N, Prinz C, et al. Cheyne–Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur. Respir. J.32(1), 61–74 (2011).
   Google Scholar
• Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. BHJ73(3), 237–241 (1991).
   Google Scholar
• Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest131, 130–135 (2007).
   PubMed Web of Science ®Google Scholar
• Rubin AE, Gottlieb SH, Gold AR et al. Elimination of central sleep apnoea by mitral valvuloplasty: the role of feedback delay in periodic breathing. Thorax9, 174–176 (2004).
   Google Scholar
• Yiu KH, Lee KL, Lau CP et al. Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea. Pacing Clin. Electrophysiol.1(12), 1522–1527 (2008).
   Google Scholar
• Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace13(8), 1174–1179 (2011).
   PubMed Web of Science ®Google Scholar
• Sredniawa B, Lenarczyk R, Kowalski O et al. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy. Europace11(1), 106–114 (2009).
   PubMed Web of Science ®Google Scholar
• Collop NA. Cheyne–Stokes ventilation converting to obstructive sleep apnea following heart transplantation. Chest104, 1288–1289 (1993).
   PubMed Web of Science ®Google Scholar
• Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am. J. Respir. Crit. Care Med.173, 234–237 (2003).
   Google Scholar
• Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N. Engl. J. Med.335, 562–567 (1996).
   PubMed Web of Science ®Google Scholar
• Sasayama S, Izumi T, Matsuzaki M et al.; CHF-HOT Study Group. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ. J.73(7), 1255–1262 (2009).
   PubMed Web of Science ®Google Scholar
• Lorenzi-Filho G, Rankin F, Bies I et al. Effects of inhaled carbon dioxide and oxygen on Cheyne–Stokes respiration in patients with heart failure. Am. J. Respir. Crit. Care Med.159, 1490–1498 (1999).
   PubMed Web of Science ®Google Scholar
• Arzt M, Wensel R, Montalvan S et al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest134(1), 1–66 (2008).
   PubMed Web of Science ®Google Scholar
• Bradley T, Logan A, Kimoff R et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med.353, 2025–2033 (2005).
   PubMed Web of Science ®Google Scholar
• Arzt M, Floras J, Logan A et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. Circulation115, 3173–3180 (2007).
   PubMed Web of Science ®Google Scholar
• Haruki N, Takeuchi M, Kaku K et al. Comparison of acute and chronic impact of adaptive servo-ventilation on left chamber geometry and function in patients with chronic heart failure. Eur. J. Heart Fail.13(10), 1140–1146 (2011).
   PubMed Web of Science ®Google Scholar
• Kasai T, Usui Y, Yoshioka T et al.; JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne–Stokes respiration. Circ. Heart Fail.3(1), 140–148 (2010).
   PubMed Web of Science ®Google Scholar
• Koyama T, Watanabe H, Terada S et al. Adaptive servo-ventilation improves renal function in patients with heart failure. Respir. Med.105(12), 1946–1953 (2011).
   PubMed Web of Science ®Google Scholar